Watson Pharmaceuticals, Inc. (NYSE:WPI)
CAPS Rating:
The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.
Growing the love for investing
The Company is engaged in the development, manufacture, marketing, sale and distribution of brand and off-patent pharmaceutical products.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
I know its not a true drug maker, mainly deals in generics. But hey, with this world gettin hooked on the meds more each year what's wrong with the cheap drugs--especially with DEMS headed to whitehouse etc... Also, I hear they have like 60 apps pending with FDA for some new pipeline drugs at approx 2 billion in revenue's possible. Not a huge % gainer but steady makes you rich if your young (like me 35-hope that is young-relatively anyway)